Hepatocellular carcinoma (HCC) is one of the most prevalent cancers globally. In contrast to
the declining death rates observed for all other common cancers such as breast, lung, and …

Artificial intelligence (AI) has experienced substantial progress over the last ten years in
many fields of application, including healthcare. In hepatology and pancreatology, major …

Doxorubicin (DOX) is an effective antitumor drug; however, but its clinical application is
seriously limited by the cardiotoxicity induced by its use. Recent studies have found that …

Patients diagnosed with hepatocellular carcinoma (HCC) suffered a high risk of recurrence
and poor prognosis. Identification of differentially expressed genes (DEGs) in HCC provides …

Hepatocellular carcinoma (HCC) is a common malignant cancer with poor survival
outcomes, and hepatitis B virus (HBV) infection is most likely to contribute to HCC. But the …

Hepatocellular carcinoma (HCC) is a grievous tumor with an increasing incidence
worldwide. Basic transcription factor 3 (BTF3) is discovered to regulate the expression of …

Pancreatic ductal adenocarcinoma (PDAC) is a class of the commonest malignant
carcinomas. The present study aimed to elucidate the potential biomarker and prognostic …

Ethnopharmacological relevance Cardiovascular and cerebrovascular diseases have
become a severe threat for human health worldwide, however, optimal therapeutic options …

Background and Objective: Hepatocellular carcinoma (HCC) is a highly aggressive
malignant tumor of the digestive system worldwide. Chronic hepatitis B virus (HBV) infection …

Chronic infection with hepatitis B virus (HBV) has long been recognized as a dominant
hazard factor for hepatocellular carcinoma (HCC) and accounts for at least half of HCC …